HEADER HYDROLASE/HYDROLASE INHIBITOR 02-MAY-09 3HAW TITLE CRYSTAL STRUCTURE OF [L-ALA51/51']HIV-1 PROTEASE WITH REDUCED ISOSTERE TITLE 2 MVT-101 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: [L-ALA51/51']HIV-1 PROTEASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 3.4.23.16; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: TOTAL CHEMICAL SYNTHESIS KEYWDS BETA BARREL, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR V.Y.TORBEEV,S.B.H.KENT REVDAT 2 11-JAN-12 3HAW 1 JRNL VERSN REVDAT 1 27-APR-11 3HAW 0 JRNL AUTH V.Y.TORBEEV,H.RAGHURAMAN,D.HAMELBERG,M.TONELLI,W.M.WESTLER, JRNL AUTH 2 E.PEROZO,S.B.KENT JRNL TITL PROTEIN CONFORMATIONAL DYNAMICS IN THE MECHANISM OF HIV-1 JRNL TITL 2 PROTEASE CATALYSIS. JRNL REF PROC.NATL.ACAD.SCI.USA V. 108 20982 2011 JRNL REFN ISSN 0027-8424 JRNL PMID 22158985 JRNL DOI 10.1073/PNAS.1111202108 REMARK 2 REMARK 2 RESOLUTION. 1.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 43001 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.187 REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.223 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2282 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.33 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2989 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 93.39 REMARK 3 BIN R VALUE (WORKING SET) : 0.2140 REMARK 3 BIN FREE R VALUE SET COUNT : 164 REMARK 3 BIN FREE R VALUE : 0.2590 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1514 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 59 REMARK 3 SOLVENT ATOMS : 117 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 15.96 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.26000 REMARK 3 B22 (A**2) : 0.22000 REMARK 3 B33 (A**2) : 0.05000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.060 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.059 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.034 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.629 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.962 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.949 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1601 ; 0.016 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1093 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2166 ; 1.672 ; 1.995 REMARK 3 BOND ANGLES OTHERS (DEGREES): 2694 ; 0.940 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 198 ; 5.844 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 56 ;38.357 ;24.643 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 282 ;13.053 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 9 ;13.122 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 258 ; 0.104 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1699 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 275 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 202 ; 0.197 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 1113 ; 0.197 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 735 ; 0.172 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 902 ; 0.088 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 52 ; 0.135 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 15 ; 0.218 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 49 ; 0.274 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 5 ; 0.239 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1039 ; 1.993 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 422 ; 1.335 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1644 ; 2.741 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 633 ; 3.897 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 522 ; 5.446 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1 A 99 REMARK 3 ORIGIN FOR THE GROUP (A): 15.9586 0.3888 18.6755 REMARK 3 T TENSOR REMARK 3 T11: -0.0014 T22: 0.0171 REMARK 3 T33: -0.0080 T12: 0.0014 REMARK 3 T13: -0.0011 T23: -0.0068 REMARK 3 L TENSOR REMARK 3 L11: 0.1756 L22: 0.1875 REMARK 3 L33: 0.3699 L12: 0.0107 REMARK 3 L13: 0.2169 L23: 0.1512 REMARK 3 S TENSOR REMARK 3 S11: 0.0004 S12: 0.0630 S13: -0.0050 REMARK 3 S21: 0.0281 S22: 0.0384 S23: -0.0144 REMARK 3 S31: 0.0063 S32: 0.0885 S33: -0.0388 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 1 B 99 REMARK 3 ORIGIN FOR THE GROUP (A): -5.8827 1.7570 17.2357 REMARK 3 T TENSOR REMARK 3 T11: 0.0034 T22: -0.0077 REMARK 3 T33: 0.0010 T12: -0.0004 REMARK 3 T13: -0.0005 T23: -0.0021 REMARK 3 L TENSOR REMARK 3 L11: 0.1709 L22: 0.1104 REMARK 3 L33: 0.2215 L12: -0.0504 REMARK 3 L13: -0.0378 L23: 0.0519 REMARK 3 S TENSOR REMARK 3 S11: 0.0047 S12: 0.0198 S13: -0.0124 REMARK 3 S21: 0.0130 S22: -0.0174 S23: 0.0332 REMARK 3 S31: 0.0104 S32: -0.0095 S33: 0.0127 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 0 B 5 REMARK 3 ORIGIN FOR THE GROUP (A): 5.3842 -0.6424 12.4912 REMARK 3 T TENSOR REMARK 3 T11: 0.0060 T22: 0.0050 REMARK 3 T33: -0.0100 T12: 0.0058 REMARK 3 T13: 0.0042 T23: -0.0033 REMARK 3 L TENSOR REMARK 3 L11: 2.1792 L22: 5.2817 REMARK 3 L33: 3.7294 L12: -3.0647 REMARK 3 L13: 2.5731 L23: -4.2725 REMARK 3 S TENSOR REMARK 3 S11: 0.0883 S12: 0.1458 S13: 0.0706 REMARK 3 S21: -0.1170 S22: -0.1977 S23: -0.1270 REMARK 3 S31: 0.0813 S32: 0.2029 S33: 0.1094 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3HAW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-MAY-09. REMARK 100 THE RCSB ID CODE IS RCSB052909. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-JUL-06 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97934 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL CRYO-COOLED REMARK 200 SI(111) REMARK 200 OPTICS : SI(111) DOUBLE CRYSTAL REMARK 200 MONOCHROMETER. ADJUSTABLE REMARK 200 FOCUSING MIRRORS IN K-B GEOMETRY REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 45561 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.300 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 200 DATA REDUNDANCY : 5.200 REMARK 200 R MERGE (I) : 0.07500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 21.8600 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.35 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.9 REMARK 200 DATA REDUNDANCY IN SHELL : 5.00 REMARK 200 R MERGE FOR SHELL (I) : 0.88000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.310 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.87 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M CITRATE, 0.2 M SODIUM PHOSPHATE. REMARK 280 30% (V/V) AMMONIUM SULFATE, 10% (V/V) DMSO, PH 6.0, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.63450 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 30.66800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.39150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 30.66800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.63450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 29.39150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: 1 REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4380 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9510 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -38.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 630 REMARK 630 MOLECULE TYPE: NULL REMARK 630 MOLECULE NAME: N-{(2S)-2-[(N-ACETYL-L-THREONYL-L-ISOLEUCYL)AMINO] REMARK 630 HEXYL}-L-NORLEUCYL-L-GLUTAMINYL-N~5~-[AMINO(IMINIO)METHYL]-L- REMARK 630 ORNITHINAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 2NC B 0 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: ACE THR ILE 2A0 GLN ARG NH2 REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2NC B 0 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3FSM RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF [L-ALA51;D-ALA51']HIV-1 PROTEASE WITH REMARK 900 REDUCED ISOSTERE MVT-101 INHIBITOR REMARK 900 RELATED ID: 3GI0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF [L-ALA51;D-ALA51']HIV-1 PROTEASE WITH REMARK 900 JG-365 INHIBITOR REMARK 900 RELATED ID: 3HAU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 PROTEASE WITH REDUCED ISOSTERE REMARK 900 MVT-101 INHIBITOR DBREF 3HAW A 1 99 PDB 3HAW 3HAW 1 99 DBREF 3HAW B 1 99 PDB 3HAW 3HAW 1 99 SEQRES 1 A 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 A 99 ARG ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 A 99 GLY ALA ASP ASP THR VAL ILE GLU GLU NLE ASN LEU PRO SEQRES 4 A 99 GLY SMC TRP LYS PRO LYS NLE ILE GLY GLY ILE ALA GLY SEQRES 5 A 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE PRO VAL GLU SEQRES 6 A 99 ILE ABA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 A 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 A 99 GLN ILE GLY ABA THR LEU ASN PHE SEQRES 1 B 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 B 99 ARG ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 B 99 GLY ALA ASP ASP THR VAL ILE GLU GLU NLE ASN LEU PRO SEQRES 4 B 99 GLY SMC TRP LYS PRO LYS NLE ILE GLY GLY ILE ALA GLY SEQRES 5 B 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE PRO VAL GLU SEQRES 6 B 99 ILE ABA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 B 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 B 99 GLN ILE GLY ABA THR LEU ASN PHE MODRES 3HAW NLE A 36 LEU NORLEUCINE MODRES 3HAW SMC A 41 CYS S-METHYLCYSTEINE MODRES 3HAW NLE A 46 LEU NORLEUCINE MODRES 3HAW ABA A 67 ALA ALPHA-AMINOBUTYRIC ACID MODRES 3HAW ABA A 95 ALA ALPHA-AMINOBUTYRIC ACID MODRES 3HAW NLE B 36 LEU NORLEUCINE MODRES 3HAW SMC B 41 CYS S-METHYLCYSTEINE MODRES 3HAW NLE B 46 LEU NORLEUCINE MODRES 3HAW ABA B 67 ALA ALPHA-AMINOBUTYRIC ACID MODRES 3HAW ABA B 95 ALA ALPHA-AMINOBUTYRIC ACID HET NLE A 36 8 HET SMC A 41 7 HET NLE A 46 8 HET ABA A 67 6 HET ABA A 95 6 HET NLE B 36 8 HET SMC B 41 7 HET NLE B 46 8 HET ABA B 67 6 HET ABA B 95 6 HET 2NC B 0 54 HET SO4 B 401 5 HETNAM NLE NORLEUCINE HETNAM SMC S-METHYLCYSTEINE HETNAM ABA ALPHA-AMINOBUTYRIC ACID HETNAM 2NC N-{(2S)-2-[(N-ACETYL-L-THREONYL-L-ISOLEUCYL) HETNAM 2 2NC AMINO]HEXYL}-L-NORLEUCYL-L-GLUTAMINYL-N~5~- HETNAM 3 2NC [AMINO(IMINIO)METHYL]-L-ORNITHINAMIDE HETNAM SO4 SULFATE ION HETSYN 2NC P2/NC FORMUL 1 NLE 4(C6 H13 N O2) FORMUL 1 SMC 2(C4 H9 N O2 S) FORMUL 1 ABA 4(C4 H9 N O2) FORMUL 3 2NC C35 H68 N11 O8 1+ FORMUL 4 SO4 O4 S 2- FORMUL 5 HOH *117(H2 O) HELIX 1 1 GLY A 86 THR A 91 1 6 HELIX 2 2 GLN A 92 GLY A 94 5 3 HELIX 3 3 GLY B 86 THR B 91 1 6 SHEET 1 A 4 GLN A 2 ILE A 3 0 SHEET 2 A 4 THR B 96 ASN B 98 -1 O LEU B 97 N ILE A 3 SHEET 3 A 4 THR A 96 ASN A 98 -1 N THR A 96 O ASN B 98 SHEET 4 A 4 GLN B 2 ILE B 3 -1 O ILE B 3 N LEU A 97 SHEET 1 B 8 LYS A 43 GLY A 48 0 SHEET 2 B 8 PHE A 53 ILE A 66 -1 O GLN A 58 N LYS A 43 SHEET 3 B 8 HIS A 69 VAL A 77 -1 O VAL A 77 N ARG A 57 SHEET 4 B 8 VAL A 32 ILE A 33 1 N ILE A 33 O LEU A 76 SHEET 5 B 8 ILE A 84 ILE A 85 -1 O ILE A 84 N VAL A 32 SHEET 6 B 8 GLN A 18 LEU A 24 1 N LEU A 23 O ILE A 85 SHEET 7 B 8 LEU A 10 ILE A 15 -1 N VAL A 11 O ALA A 22 SHEET 8 B 8 PHE A 53 ILE A 66 -1 O GLU A 65 N ARG A 14 SHEET 1 C 8 LYS B 43 GLY B 48 0 SHEET 2 C 8 PHE B 53 ILE B 66 -1 O GLN B 58 N LYS B 43 SHEET 3 C 8 HIS B 69 VAL B 77 -1 O HIS B 69 N ILE B 66 SHEET 4 C 8 VAL B 32 ILE B 33 1 N ILE B 33 O LEU B 76 SHEET 5 C 8 ILE B 84 ILE B 85 -1 O ILE B 84 N VAL B 32 SHEET 6 C 8 GLN B 18 LEU B 24 1 N LEU B 23 O ILE B 85 SHEET 7 C 8 LEU B 10 ILE B 15 -1 N ILE B 13 O LYS B 20 SHEET 8 C 8 PHE B 53 ILE B 66 -1 O GLU B 65 N ARG B 14 LINK C GLU A 35 N NLE A 36 1555 1555 1.33 LINK C NLE A 36 N ASN A 37 1555 1555 1.34 LINK C GLY A 40 N SMC A 41 1555 1555 1.32 LINK C SMC A 41 N TRP A 42 1555 1555 1.32 LINK C LYS A 45 N NLE A 46 1555 1555 1.31 LINK C NLE A 46 N ILE A 47 1555 1555 1.34 LINK C ILE A 66 N ABA A 67 1555 1555 1.33 LINK C ABA A 67 N GLY A 68 1555 1555 1.33 LINK C GLY A 94 N ABA A 95 1555 1555 1.33 LINK C ABA A 95 N THR A 96 1555 1555 1.33 LINK C GLU B 35 N NLE B 36 1555 1555 1.32 LINK C NLE B 36 N ASN B 37 1555 1555 1.33 LINK C GLY B 40 N SMC B 41 1555 1555 1.32 LINK C SMC B 41 N TRP B 42 1555 1555 1.33 LINK C LYS B 45 N NLE B 46 1555 1555 1.33 LINK C NLE B 46 N ILE B 47 1555 1555 1.34 LINK C ILE B 66 N ABA B 67 1555 1555 1.34 LINK C ABA B 67 N GLY B 68 1555 1555 1.32 LINK C GLY B 94 N ABA B 95 1555 1555 1.33 LINK C ABA B 95 N THR B 96 1555 1555 1.33 SITE 1 AC1 21 ASP A 25 GLY A 27 ALA A 28 ASP A 29 SITE 2 AC1 21 GLY A 48 GLY A 49 VAL A 82 ASP B 25 SITE 3 AC1 21 GLY B 27 ALA B 28 ASP B 29 ASP B 30 SITE 4 AC1 21 ILE B 47 GLY B 48 GLY B 49 ILE B 50 SITE 5 AC1 21 VAL B 82 HOH B 105 HOH B 113 HOH B 133 SITE 6 AC1 21 HOH B 158 SITE 1 AC2 6 GLY A 16 GLY A 17 PRO A 63 HOH A 138 SITE 2 AC2 6 ARG B 14 GLY B 17 CRYST1 51.269 58.783 61.336 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019505 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017012 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016304 0.00000 MASTER 339 0 12 3 20 0 8 6 0 0 0 16 END